2000
DOI: 10.1002/1529-0131(200002)43:2<461::aid-anr29>3.0.co;2-7
|View full text |Cite
|
Sign up to set email alerts
|

Rheumatoid arthritis exacerbation caused by exogenous interleukin-12

Abstract: Interleukin-12 (IL-12) is a pleiotropic cytokine with proinflammatory, immunoregulatory, antitumor, and antimetastatic properties. It plays a crucial role in the development of the Th1 response and subsequent interferon-gamma production and enhancement of cell-mediated cytotoxicity. Recently, IL-12 has been used as an experimental therapy for cancer. Given the multiple immunomodulatory properties of IL-12, there are potential concerns associated with its clinical use. Of special interest are the possible side … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0
1

Year Published

2001
2001
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(10 citation statements)
references
References 7 publications
1
8
0
1
Order By: Relevance
“…These findings suggest that blocking IL-12 with mAbs may be a useful therapeutic strategy for RA. Consistent with our suggestion, it was reported that RA is exacerbated by multiple injections of IL-12 for therapeutic purposes in metastatic cervical cancer (27). Alternatively, strategies to block the functional activity of IL-12R-expressing effector cells, such as NKT cells may also be helpful in treating RA.…”
Section: Discussionsupporting
confidence: 89%
“…These findings suggest that blocking IL-12 with mAbs may be a useful therapeutic strategy for RA. Consistent with our suggestion, it was reported that RA is exacerbated by multiple injections of IL-12 for therapeutic purposes in metastatic cervical cancer (27). Alternatively, strategies to block the functional activity of IL-12R-expressing effector cells, such as NKT cells may also be helpful in treating RA.…”
Section: Discussionsupporting
confidence: 89%
“…[48][49][50][51] Reciprocally, administration of recombinant IFN-␥ to treat malignant or infectious diseases can result in manifestation or exacerbation of autoimmune symptoms, 52 an effect that was also attributed to the IFN-␥-inducing factor IL-12. 53 Consequences of IFN-␥ release in the inflamed tissue include induction of other proinflammatory mediators, such as IL-6, IL-8, and IL-15, as was demonstrated in coculture experiments of synovial T cells with synovial fibroblasts from active RA patients. 54 Although several rodent arthritis models substantiate the view that IFN-␥ contributes to joint inflammation, [55][56][57][58] IFN-␥-secreting Th cells may also serve regulatory functions by restriction of the primary expansion of Th1 cells and suppression of Th17 cell development.…”
Section: Discussionmentioning
confidence: 94%
“…The role of IL‐12 in the induction of chronic Th1‐mediated diseases, such as experimental colitis and arthritis, is well known. IL‐12 exposure or the use of IL‐12‐deficient mice has revealed that IL‐12 is a crucial immune‐stimulatory cytokine for the development of experimentally induced arthritis (13, 15, 16). This is the first study showing that local overexpression of IL‐12 in combination with an acute inflammation generates a chronic immune‐mediated destructive process.…”
Section: Discussionmentioning
confidence: 99%